坎迪达光:流行病学和抗真菌战略
1Department of Medicine and Department of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, Wisconsin, USA;
Annual review of medicine
|December 10, 2024
概括
黄菌 (Candida auris) 是一种有弹性的真菌病原体,由于皮肤殖民和抗真菌耐药性,在医疗机构中很容易传播. 了解它的流行病学和耐药性是控制疫情的关键.
科学领域:
- 医学真菌学 医学真菌学
- 传染性疾病 传染性疾病
- 流行病学 流行病学
背景情况:
- 黄是一种新兴的全球性真菌病原体,导致严重的医疗相关感染.
- 它殖民皮肤的能力促进了广泛的传播和医疗机构的爆发.
- C. auris表现出显著的抗真菌耐药性和环境持久性,使感染控制复杂化.
研究的目的:
- 审查关于Candida auris流行病学和抗真菌耐药性的关键研究.
- 讨论这些因素对医疗保健相关传播的影响.
- 突出流行病学模式和耐药性如何指导治疗策略.
主要方法:
- 关于Candida auris.的最新科学文献的审查.
- 对专注于流行病学,殖民地和风险因素的研究进行分析.
- 检查有关抗真菌耐药性模式的数据.
主要成果:
- 识别经常被殖民的皮肤部位和侵入性感染的风险因素.
- 在C. auris菌株中对抗真菌耐药性资料的表征.
- 在医疗保健环境中存在C. auris的证据.
结论:
- 由于其独特的殖民和抵抗性质,Candida auris构成重大威胁.
- 流行病学见解和耐药性数据对于有效的预防和治疗至关重要.
- 需要有针对性的干预措施来打击C. auris的传播和管理感染.
相关概念视频
Healthcare Associated Infections II: Preventive Measures
4.7K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.7K
Fungal Phylum Microsporidia
787
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
787
Mechanism of Antibiotic Resistance in MRSA
245
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
245
Antifungal Agents
131
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
131
Clinical Significance of Antibiotic Resistance
106
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
106


